The growth of the oral commensal Streptococcus gordonii in saliva may depend on a number of glycoside hydrolases (GHs), including three cell wall-anchored proteins that are homologs of pneumococcal ␤-galactosidase (BgaA), ␤-N-acetylglucosaminidase (StrH), and endo-␤-N-acetylglucosaminidase D (EndoD). In the present study, we introduced unmarked in-frame deletions into the corresponding genes of S. gordonii DL1, verified the presence (or absence) of the encoded proteins on the resulting mutant strains, and compared these strains with wild-type strain DL1 for growth and glycan foraging in saliva. The overnight growth of wild-type DL1 was reduced 3-to 10-fold by the deletion of any one or two genes and approximately 20-fold by the deletion of all three genes. The only notable change in the salivary proteome associated with this reduction of growth was a downward shift in the apparent molecular masses of basic proline-rich glycoproteins (PRG), which was accompanied by the loss of lectin binding sites for galactose-specific Erythrina cristagalli agglutinin (ECA) and mannose-specific Galanthus nivalis agglutinin (GNA). The binding of ECA to PRG was also abolished in saliva cultures of mutants that expressed cell surface BgaA alone or together with either StrH or EndoD. However, the subsequent loss of GNA binding was seen only in saliva cocultures of different mutants that together expressed all three cell surface GHs. The findings indicate that the growth of S. gordonii DL1 in saliva depends to a significant extent on the sequential actions of first BgaA and then StrH and EndoD on N-linked glycans of PRG.
T he development of dental plaque in the absence of exogenous nutrients has long been thought to depend on bacterial foraging of host salivary glycans (1, 2) . Little is known, however, about how different oral species attack and utilize salivary macromolecules as substrates for growth and whether cross-feeding between species influences dental plaque biofilm development. Recently, we compared the growth of different oral bacteria in filter-sterilized saliva that was first heat treated to inactivate endogenous glycoside hydrolases and then dialyzed to remove possible lowmolecular-mass growth substrates. Growth through two transfers in this model system was observed elsewhere for strains of Streptococcus gordonii, Streptococcus oralis, and Streptococcus mitis but not for strains of certain other species, including Actinomyces spp., Abiotrophia defectiva, Rothia spp., Streptococcus salivarius, Streptococcus sanguinis, Streptococcus sobrinus, and Streptococcus vestibularis, which grew poorly or not at all (3) . Importantly, the growth of the first three streptococcal species mentioned above was accompanied by degradation of basic proline-rich glycoproteins (PRG), whereas species that failed to grow did not alter the electrophoretic mobility or lectin reactivity of PRG nor any other salivary component.
S. gordonii strain DL1 (i.e., Challis) was one of the streptococci that grew well in saliva and appeared to utilize PRG as a growth substrate. Annotation of this strain in the Carbohydrate-Active Enzymes database (CAZy; www.cazy.org) revealed 31 putative glycoside hydrolases (GHs) distributed among 16 GH families. Based on specific GH activities associated with these families, we surmised that host glycan foraging could involve at least 17 putative GHs of S. gordonii. Of these, three were identified as cell wall-anchored proteins based on the predicted presence of Nterminal signal peptides and C-terminal sorting motifs (4) . Moreover, these three proteins were homologues of Streptococcus pneumoniae ␤-galactosidase (BgaA), ␤-N-acetylglucosaminidase (StrH), and endo-␤-N-acetylglucosaminidase D (EndoD), which are known to act on host glycans (5, 6) and, in the case of BgaA and StrH, to promote the growth of S. pneumoniae on the human serum component ␣-1 acid glycoprotein (7) . Based on the information summarized above, we hypothesized that BgaA, StrH, and EndoD of S. gordonii are critical for salivary glycan foraging. To test this hypothesis, we deleted the genes for these proteins in different combinations from S. gordonii DL1 and then compared the growth of the wild-type and mutant strains in saliva. The results indicate that the growth of S. gordonii DL1 depends to a significant extent on sequential action of the three cell surface GHs on N-linked glycans of salivary PRG.
MATERIALS AND METHODS
Plasmids and bacterial strains. The plasmids listed in Table 1 were purified by using QIAprep spin miniprep kits (Qiagen) from Escherichia coli DH5␣ grown in LB broth containing either ampicillin (75 g/ml) or erythromycin (500 g/ml) to maintain antibiotic resistance. Wild-type S. gordonii DL1 and glycoside hydrolase deletion mutant (⌬GH mutant) strains (Table 1) were maintained at Ϫ70°C as frozen stock cultures in Todd-Hewitt broth (THB; Oxoid) containing 40% glycerol and were transferred to THB or another complex medium, as indicated below, at the beginning of each experiment.
Plasmid construction. Unmarked in-frame deletions were introduced into S. gordonii DL1 using a nonreplicative allelic exchange vector similar to pCWU3, which was developed for use in Actinomyces oris (11) . We found that the kanamycin resistance and mCherry fluorescence markers of pCWU3 were not optimal for allelic exchange in S. gordonii DL1, and we therefore prepared a similar plasmid, designated pEG ( Fig. 1 and Table 1 ), that contained the ermAM cassette and expressed green fluorescent protein (GFP) from the constitutive S. gordonii promoter, PrpsJ. The ermAM cassette was amplified by PCR from pKSerm2 using KOD hot start DNA polymerase (Novagen) and primers ermAM-F/ermAM-R (Table 2). The resulting PCR product was cloned into the AclI site of dephosphorylated pUC19c to obtain pUC19c-1. The 198-bp sequence designated PrpsJ, which is located immediately upstream from rpsJ (i.e., SGO_1986), was amplified from S. gordonii DL1 genomic DNA with primer pair rpsJ-F/rpsJ-R. The 720-bp sequence of gfp (including two TAA stop codons) was codon optimized for expression in S. gordonii and synthesized by Blue Heron Biotechnology, Inc. (Bothell, WA). The optimized sequence was amplified from a gfp-containing derivative of pBR322 using primer pair gfp-F/gfp-R. The sequences of PrpsJ and gfp were linked by overlap extension PCR performed with primer pair rps-F/gfp-R and using the corresponding PCR products as the template. The resulting 0.9-kb PCR product (PrpsJ-gfp) was cloned into the EcoRI site of ermAM-containing pUC19c-1 to obtain pEG.
Gene exchange cassettes containing deletion constructs of S. gordonii DL1 bgaA, strH, or endoD (i.e., SGO_1486, SGO_0405, or SGO_0208, respectively) flanked by approximately 1-kb adjacent gene-targeting sequences were prepared from overlapping PCR products amplified from genomic DNA with primer pairs (Table 1) GH2-1/GH2-2 and GH2-3/ GH2-4, GH20-1/GH20-2 and GH20-3/GH20-4, and GH85-1/GH85-2 and GH85-3/GH85-4. The deletions in the gene exchange cassettes removed residues 32 to 2303 from the 2,350-amino-acid-coding sequence of bgaA, residues 27 to 1129 from the 1,142-amino-acid-coding sequence of strH, and residues 25 to 1532 from the 1,545-amino-acid-coding sequence of endoD. Each cassette was cloned into pEG as indicated in Table  1 to obtain pEG⌬bgaA, pEG⌬strH, or pEG⌬endoD, respectively.
Isolation of ⌬GH mutants. Transformation of S. gordonii DL1 was performed as previously described (12) by incubating early-log-phase cells with 30 to 50 ng of pEG⌬bgaA, pEG⌬strH, or pEG⌬endoD. Reaction mixtures were plated on brain heart infusion (BHI) agar (Oxoid) containing 10 g/ml erythromycin to select for Em r transformants that also expressed gfp from the integrated plasmid. Integration of each plasmid at the target site was confirmed by PCR performed with primers designed from adjacent plasmid and S. gordonii chromosomal sequences ( Table 2 , primers UC19-F with GH2-6, GH20-6, or GH85-6 and UC19-R with GH2-5, GH20-5, or GH85-5). Plasmid-bearing clones were then transferred and passaged several times in antibiotic-free medium to allow excision of integrated plasmids (accompanied by loss of Em r and GFP fluorescence) prior to plating. Plasmid-free (nonfluorescent) colonies were typically seen at frequencies of from 10 Ϫ2 to 10 Ϫ3 and were distinguished from plasmid-bearing (fluorescent) colonies using a Fuji image reader. The nonfluorescent colonies were screened by PCR with primer pairs that amplified across deletions (Table 2, GH2-F/GH2-R, GH20-F/GH20-R, or GH85-F/GH85-R) to distinguish wild-type bacteria from ⌬GH mutants. PCR products amplified from ⌬GH mutants were also sequenced to confirm deletions in these strains.
Mutants with deletions in more than one gene were obtained by repeating the procedure described above. As summarized in Table 1 , ⌬bgaA ⌬strH, ⌬bgaA ⌬endoD, and ⌬strH ⌬endoD double mutants (i.e., strains ⌬A/H, ⌬A/D, and ⌬H/D, respectively) were derived from ⌬strH or ⌬endoD single mutants (i.e., strains ⌬H or ⌬D, respectively), and the ⌬bgaA ⌬strH ⌬endoD triple mutant (i.e., strain ⌬A/H/D) was derived from the ⌬bgaA ⌬endoD double mutant (i.e., strain ⌬A/D).
Enzyme assays. Bacteria cultured in THB, heart infusion broth (HIB; Becton, Dickinson), or whole saliva were washed in saliva-salts buffer Immunological methods. N-terminally polyhistidine (6ϫHis)-tagged recombinant proteins containing the putative catalytic region of each cell surface GH were prepared for use as immunogens. The nucleotide sequences for amino acid residues 80 to 609 of BgaA (13, 14) , 136 to 507 of StrH (15, 16) , and 113 to 762 of EndoD (17), including in-frame 5=-BamHI and 3=-HindIII cloning sites and the requisite start (ATG) and stop codons (TAA or TGA), were optimized for expression in E. coli, synthesized, and cloned into pTrcHisB (Invitrogen) by Blue Heron Biotechnology, Inc. Plasmid-bearing E. coli EC100 bacteria were grown at 37°C with aeration in Luria-Bertani broth supplemented with ampicillin (150 g/ml). At an A 600 of 0.4, the cultures were rapidly chilled in ice water, and isopropyl thiogalactopyranoside (IPTG) was added to a final concentration of 1 mM. Cultures were then incubated for an additional 6 h at 24°C (to preclude the formation of inclusion bodies). Cells were harvested by centrifugation (13,000 ϫ g for 15 min at 5°C), washed by resuspension and centrifugation in 25 mM Tris-HCl (pH 7.5) buffer, homogenized in 2.5 volumes of buffer, and disrupted by sonication on ice. The extracts were clarified by high-speed centrifugation (180,000 ϫ g for 1 h at 5°C) and applied to small columns of Ni 2ϩ -nitrilotriacetic acid (NTA)-agarose. The columns were rinsed with wash buffer (50 mM Tris-HCl, 0.5 M NaCl, and 20 mM imidazole, pH 8.0) to remove unbound material and eluted with 0.5 M imidazole (in wash buffer) to obtain 6ϫHis BgaA (60. 4 
Complementary sequences in overlapping primer pairs are shown in boldface, and cleavage sites for restriction endonucleases (parentheses) are underlined.
were prepared at Covance Research Products (Denver, PA) by subcutaneous injections of the antigen in Freund's adjuvant following standard protocols. Dot immunoblotting was performed with bacteria from overnight HIB cultures that were spotted (ϳ6 ϫ 10 7 bacteria per 3-mm spot) on nitrocellulose membranes with a Bio-Dot microfiltration apparatus (Bio-Rad). Membranes were blocked in Tris-buffered saline containing 0.1% Tween 20 and 2% skim milk and then incubated with 1/1,000 anti-GH antiserum that was first preabsorbed at a dilution of 1/10 with triple mutant strain ⌬A/H/D to remove background anti-S. gordonii antibody. Bound anti-GH antibody was detected using horseradish peroxidase-conjugated goat anti-rabbit IgG (Bio-Rad) and a metal-enhanced 3,3=-diaminobenzidine (DAB) substrate kit (Life Technologies).
Growth of bacteria in saliva. The protocol used to measure planktonic growth of bacteria in saliva is described elsewhere (3). Briefly, whole saliva from a single donor was periodically collected on ice, reduced with dithiothreitol to facilitate sterile filtration, heat treated (30 min at 70°C) to inactivate endogenous GH activities, and dialyzed against saliva-salt buffer to increase pH stability and remove possible low-molecular-mass growth substrates. Growth studies in saliva were initiated with bacteria from overnight THB cultures of S. gordonii wild-type and mutant strains that were washed and suspended in saliva to an optical density at 640 nm (OD 640 ) of 1 (ϳ1 ϫ 10 9 /ml). Primary saliva cultures were inoculated by 1/1,000 dilution of these suspensions into fresh saliva and incubated overnight at 37°C. Each primary saliva culture was then diluted 1/1,000 into three aliquots (2 ml each) of fresh saliva, and the resulting secondary saliva cultures were incubated for 24 h at 37°C, which was sufficient for maximum growth. Genomic DNA templates were prepared from bacteria that were pelleted from 1-ml aliquots of each primary or secondary saliva culture by high-speed centrifugation. Quantitative PCR (qPCR) was performed in triplicate on each template.
S. gordonii DL1 and mutant strain ⌬A/H/D were also cultured, as previously described (18), in parallel tracks of flow cells perfused with whole saliva at a flow rate of 7 l/min. Flow cells were inoculated with dilute cell suspensions (OD 540 of 0.05) of the two strains and incubated at 37°C for 0, 4, or 18 h. At each time point, the biofilm in a replicate flow cell was stained with a LIVE/DEAD BacLight bacterial viability kit (Thermo Fisher Scientific) and examined with a Meta 510 confocal microscope (Zeiss) to compare biofilm formation. Following microscopy, the staining solution was drained from the flow cells and replaced with 250 l lysis buffer for extraction and subsequent purification of genomic DNA templates for qPCR.
Biochemical analysis of saliva. Saliva from uninoculated control and secondary growth cultures was filtered (0.22-m-pore-size cellulose nitrate membrane) and assayed in triplicate for protein and carbohydrate, using a bicinchoninic acid (BCA) protein assay kit (ThermoFisher) for protein, with bovine serum albumin as the standard, and the phenolsulfuric acid assay for carbohydrate (19) , with glucose as the standard. SDS-PAGE of reduced saliva was performed as described elsewhere (3), using NuPAGE 4 to 12% Bis-Tris minigels in morpholinepropanesulfonic acid (MOPS) buffer, followed by silver staining (SilverQuest silver staining kit; Invitrogen). An ϳ70-kDa band was excised from a silver-stained gel of control saliva and destained by following the recommendations in the SilverQuest silver staining kit. The excised band was rinsed with 50 mM bicarbonate, reduced with dithiothreitol, and alkylated with iodoacetamide prior to overnight digestion with trypsin (Promega). Tryptic peptides were separated and identified by nanoscale liquid chromatography coupled to tandem mass spectrometry (NanoLC-MS/MS) performed by Applied Biomics, Inc. (Hayword, CA). The resulting peptide mass and associated fragmentation spectra were submitted to a GPS Explorer workstation equipped with the MASCOT search engine (Matrix Science, London, United Kingdom) to search the Swiss-Prot database. SDS-PAGEseparated salivary proteins were transferred to nitrocellulose membranes for lectin blotting, which was performed as described elsewhere (3), using fluorescein-labeled Sambucus nigra agglutinin (SNA; Vector Laboratories) at 3 g/ml, Erythrina cristagalli agglutinin (ECA; Vector Laboratories) at 2 g/ml, succinylated wheat germ agglutinin (SWGA; Vector Laboratories) at 5 g/ml, Galanthus nivalis agglutinin (GNA; EY Laboratories) at 5 g/ml, or Aleuria aurantia lectin (AAL; Vector Laboratories) at 2 g/ml. The methods for two-dimensional gel electrophoresis (isoelectric focusing on pI 3 to 10 strips, followed by SDS-PAGE on 4 to 12% Bis-Tris gels) have also been described (3).
RESULTS

Cell surface phenotypes of wild-type and ⌬GH mutant strains.
In previous studies of S. pneumoniae (6), deletion of bgaA or strH abolished the hydrolysis of 2-Np-␤-Gal or 4-Np-␤-GlcNAc, respectively, in assays performed with lysates of this streptococcus. In the present study, deletion of each gene from S. gordonii resulted in a threefold reduction in hydrolysis of the corresponding substrate in assays performed with washed HIB-grown cells. Notwithstanding contributions of other cellular enzyme activities, hydrolysis of 2-Np-␤-Gal was reduced for all mutants that lacked bgaA (strains ⌬A, ⌬A/H, ⌬A/D, and ⌬A/H/D). Likewise, hydrolysis of 4-Np-␤-GlcNAc was reduced for all mutants that lacked strH (strains ⌬H, ⌬A/H, ⌬H/D, and ⌬A/H/D). However, the activities of certain bgaA-and strH-expressing mutants were not identical to those of the wild type. Most notably, the BgaA activity (2-Np-␤-Gal hydrolysis) of mutants that expressed bgaA but lacked endoD (strains ⌬D and ⌬H/D) was about half that of the wild type, and the StrH activity (4-NP-␤-GlcNAc hydrolysis) of mutants that expressed strH but lacked bgaA (strains ⌬A and ⌬A/D) was about 4 times that of the wild type. While the basis of these observations remains to be explained, it is important to note that comparable differences in cell surface GH expression were also seen between wild-type S. gordonii DL1 cells grown in different culture media. Cells grown in HIB (no added glucose) typically had about 3 times more StrH activity than cells grown in THB (0.2% glucose). More importantly, wild-type cells grown in saliva had up to 10 times more StrH activity than cells from HIB (data not shown). Comparable studies of cell surface EndoD activity were not possible because colorimetric or fluorogenic substrates are not commercially available.
The presence of BgaA, StrH, and EndoD on strain DL1, as well as the expected presence or absence of these proteins on different ⌬GH mutant strains, was firmly established by the reactions of GH-specific rabbit antisera with bacteria grown in HIB (Fig. 2) . Importantly, the deletion of each gene abolished the binding of the corresponding GH-specific antiserum. Reduced binding of antiBgaA antiserum to mutant strains ⌬D and ⌬H/D was also noted, in accordance with the reduced BgaA activities of these strains mentioned above.
Growth of wild-type and ⌬GH mutant strains in saliva. Prior to growth studies in saliva, we compared the growth of S. gordonii DL1 and the triple mutant strain ⌬A/H/D in THB. The generation times, calculated from measurements of culture turbidity during the mid-log phase of growth, were nearly identical (ϳ54 min for each), as were the overnight cell densities (ϳ10 9 /ml for each). In striking contrast, the endpoint cell density of the triple mutant strain ⌬A/H/D in 24-h saliva cultures was approximately 20-fold lower than that of S. gordonii DL1 (Fig. 3A) . The endpoint cell densities of mutants that lacked one or two cell surface GHs were 3-to 10-fold lower than that of the wild type. Thus, the actions of cell surface BgaA, StrH, and EndoD were required for maximum growth of S. gordonii DL1 in saliva.
The growth and biofilm formation of wild-type strain DL1 and mutant strain ⌬A/H/D were also compared in parallel tracks of flow cells perfused with saliva (Fig. 4) . The biofilm formation by each strain was similar after 4 h of incubation at 37°C but was consistently greater for wild-type strain DL1 than for the triple mutant strain ⌬A/H/D after 18 h of incubation. Biovolume measurements after 18 h (Fig. 4 ) revealed 3.9 times more wild-type than mutant cells, in good agreement with the results from qPCR, which indicated a 3.5-fold difference in genomic DNA extracted from the parallel tracks. The lack of propidium iodide staining (red) in the mutant biofilm (Fig. 4B ) is also noteworthy, as it indicates that the deletions in strain ⌬A/H/D do not grossly affect membrane potential or permeability.
Biochemical characterization of saliva from growth cultures. The growth of wild-type S. gordonii DL1 in secondary saliva cultures (Fig. 3A) was associated with a 23% loss of salivary protein as measured by the BCA assay (Fig. 3B) and a 46% loss of salivary carbohydrate detected by the phenol-sulfuric acid assay (Fig. 3C) . The losses of protein and carbohydrate were significantly less in saliva cultures of all ⌬GH mutant strains, and for certain mutants, such as the triple mutant strain ⌬A/H/D, the concentrations of salivary protein and carbohydrate were the same as in control saliva. The SDS-PAGE profiles of these samples (Fig. 3D) were generally similar, except for the position of a salivary component that migrated as a diffuse 70-kDa band in the electrophoretic pattern of control saliva. This component appeared at the same position in the salivary profiles of mutants that expressed one or no cell surface GHs (strains ⌬H/D, ⌬A/D, ⌬A/H, and ⌬A/H/D) but was shifted downward in the profiles of mutants that expressed two cell surface GHs (strains ⌬A, ⌬H, and ⌬D). The same band was noticeably absent from the salivary profile of wild-type strain DL1, which instead contained additional bands that migrated be- tween 40 and 60 kDa. NanoLC-MS/MS of the trypsin-digested 70-kDa band, excised from one-dimensional gels of control saliva as indicated in Fig. 3D , identified the specific decapeptide RPQG GNQPQR derived from the nonglycosylated N-terminal regions of two salivary proline-rich proteins, PRB3 and PRB4 (20) , along with peptides from other salivary components (e.g., ␣-amylase, IgA heavy chain, and albumin) that migrate below PRB3 and -4 in SDS-PAGE.
Samples of control saliva and saliva from cultures of wild-type strain DL1 and mutant strain ⌬A/H/D were also compared by two-dimensional (2-D) gel electrophoresis. The most prominent difference between these samples involved migration of basic PRGs, which appeared in the 40-to 60-kDa region of the DL1 pattern, rather than in the 70-to 80-kDa region, as in saliva from the uninoculated control or the culture of triple mutant strain ⌬A/H/D (Fig. 5, boxed region) . A comparable shift in the apparent molecular mass of PRG isoforms that migrated between pI 8 and 10 was also seen between different samples. Thus, basic PRGs appeared to be major substrates for GH-dependent growth of S. gordonii DL1 in saliva.
To assess changes in PRG glycosylation, we transferred SDS-PAGE-separated saliva samples (Fig. 3D ) to nitrocellulose and probed the resulting transfers with fluorescein isothiocyanate (FITC)-labeled lectins that bind different features of N-linked glycans. In these experiments, PRG from control saliva appeared as a prominent ϳ70-kDa band on blots incubated with Sia-reactive SNA, Gal-reactive ECA, GlcNAc-reactive SWGA, Man-reactive GNA, and Fuc-reactive AAL (Fig. 6A) . Other, less-prominent lectin-reactive salivary components were also detected, including one at ϳ80 kDa and another between 50 and 60 kDa. Unlike PRG from control saliva, PRG from saliva cultures of S. gordonii DL1 appeared in the 40-to 60-kDa region of blots and was labeled by Sia-reactive SNA, GlcNAc-reactive SWGA, and Fuc-reactive AAL but not by either Gal-reactive ECA or Man-reactive GNA. In contrast, PRG from saliva cultures of mutants that lacked bgaA (i.e., strains ⌬A, ⌬A/H, ⌬A/D, and ⌬A/H/D) migrated as a diffuse ϳ70-kDa band and reacted strongly with all five lectins, whereas PRG from cultures of mutants that expressed bgaA (i.e., strains ⌬H, ⌬D, and ⌬H/D) migrated slightly faster than PRG from control saliva and reacted with all lectins except Gal-reactive ECA.
The loss of GNA binding to PRG was only seen in saliva cultures of S. gordonii DL1, which suggested that the actions of BgaA, StrH, and EndoD were all required for this effect. To test this hypothesis, we set up mono-and cocultures of different mutant strains that, in combination, expressed all three enzymes. In these experiments (Fig. 6B) , PRG from monocultures of mutant strains ⌬H, ⌬A/D, ⌬D, and ⌬A/H migrated and were detected (as in Fig.  6A ) by binding Man-reactive GNA and other lectins, with the exception of ECA, which failed to bind PRG from saliva cultures of mutants that expressed cell surface BgaA (strains ⌬H and ⌬D). In contrast, PRG from cocultures of strains ⌬H plus ⌬A/D or of strains ⌬D plus ⌬A/H migrated in the 40-to 60-kDa region, like PRG from saliva cultures of wild-type DL1, and bound SNA, SWGA, and AAL but not ECA or GNA. Thus, the loss of GNA reactivity resulted from the action first of BgaA and then those of StrH and EndoD.
DISCUSSION
The previous observation that the number of genes for cell wallanchored GHs was generally greater in oral streptococci that grew well in saliva, such as S. gordonii and S. oralis, than in species that failed to grow suggested an important role for these enzymes in salivary glycan foraging (3) . Four putative cell wall-anchored GHs were identified from S. gordonii DL1, of which three were predicted to act on host glycans based on their homology with pneumococcal BgaA (13, 14) , StrH (15, 16) , and EndoD (17) . In the present study, we introduced unmarked, in-frame deletions in the corresponding genes and verified cell surface expression of the encoded proteins on the resulting mutant strains by their reactions with anti-BgaA, anti-StrH, or anti-EndoD antisera (Fig. 2) . Deletion of these genes did not affect the growth of S. gordonii DL1 in glucose-containing THB medium but resulted in an ϳ20-fold reduction of cell densities in 24-h planktonic saliva cultures, as well as an ϳ4-fold reduction of biofilm formation in flowing saliva ( Fig. 3 and 4) . The only obvious change in the salivary proteome associated with the growth of S. gordonii DL1 was a reduction in the apparent molecular mass of basic PRG, which was accompanied by the loss of lectin-binding sites for Gal-specific ECA and Man-specific GNA. Importantly, these effects were not seen in saliva from cultures of mutant strain ⌬A/H/D (Fig. 5 and  6 ), which lacked all three cell surface GHs. The removal of ECA binding sites from PRG in saliva cultures of different mutant strains correlated with the cell surface expression of BgaA. However, the subsequent loss of GNA binding sites was seen only in saliva cocultures of ⌬GH mutant strains that in combination expressed all three cell surface GHs. Considered together, these findings indicate that the growth of S. gordonii DL1 in saliva depends to a considerable extent on the actions first of BgaA and then of StrH and EndoD on N-linked glycans of basic PRG.
Insight into the structural basis of salivary glycan foraging by S. gordonii was gained from NanoLC-MS/MS of the PRG band from control saliva (Fig. 3D) , which associated this component with PRB3 and PRB4. The ϳ30-kDa protein backbones of these genetically distinct proline-rich basic salivary glycoproteins (20, 21) contain proline-rich tandem-repeat regions heavily glycosylated with N-linked and, to a lesser extent, O-linked oligosaccharides (22, 23) . Twenty-seven structurally related N-linked oligosaccharides were previously identified from PRB3, the most abundant of which was a biantennary asialo-oligosaccharide with substitutions of three fucose residues (24) . The proposed sequential cleavage of this structure by BgaA, StrH, and EndoD of S. gordonii (Fig. 7) is consistent with previously determined substrate specificities of these enzymes from S. pneumoniae, as summarized by King (5) , and was demonstrated in the present study by lectin blotting of PRG from saliva cultures of S. gordonii wild-type and ⌬GH mutant strains (Fig. 6) . The binding of Sia-reactive SNA to PRG from all saliva cultures, although not expected based on the asialo structure shown in Fig. 7 , is readily explained by the presence of terminal ␣2-6-linked Sia on a similar oligosaccharide previously identified from PRB3 (24) . The fact that the growth of S. gordonii DL1 does not affect SNA binding indicates that the presence of termi- nal sialic acid protects certain N-linked glycan chains of PRG from glycan foraging by this species, which unlike S. pneumoniae (6) and certain other viridans group streptococci (25) , lacks sialidase activity.
ECA reacts well with both Gal␤1-4GlcNAc and Fuc␣1-2Gal␤1-4GlcNAc termini (26, 27) . Thus, the ability of all BgaAexpressing wild-type and ⌬GH mutant strains to abolish binding of ECA to PRG (Fig. 6) suggests cleavage of Gal from terminal Gal␤1-4GlcNAc to expose terminal GlcNAc␤1-2Man␣ and cleavage of Fuc␣1-2Gal from terminal Fuc␣1-2Gal␤1-4GlcNAc to expose terminal Fuc␣1-3GlcNAc␤1-2Man␣ (Fig. 7) . Terminal GlcNAc␤1-2Man␣ is a preferred substrate for StrH of S. pneumoniae (15) , but it remains to be determined whether this enzyme of S. gordonii also acts on the same linkage in Fuc␣1-3GlcNAc␤1-2Man␣ to expose terminal Man␣1-3Man (Fig. 7) . Our ability to detect the action of StrH by lectin blotting of PRG was limited by the specificities of currently available GlcNAc-and Fuc-binding lectin probes. Thus, GlcNAc-specific SWGA (28) has been shown to bind internal GlcNAc residues (29) and Fuc-specific AAL (30) reacts well with both ␣1-3-and ␣1-6-linked Fuc branches. Although not revealed by lectin blotting, the action of StrH was clearly required for the subsequent removal of GNA-binding structures from PRG in cocultures of mutants that expressed this enzyme in combination with BgaA and EndoD (Fig. 6B) .
The ability of GNA to detect sequential action of BgaA, StrH, and EndoD on PRG undoubtedly depends on the specificity of this lectin for terminal Man residues in branched oligosaccharides (31) like those that decorate PRB3 (Fig. 7) . This finding does not, however, imply that all GNA-reactive glycans of PRG are acted upon by EndoD. Indeed, binding of GNA to PRG from control saliva was not abolished by the growth of any mutant that expressed EndoD (i.e., strains ⌬A, ⌬H, and ⌬A/H) (Fig. 6) . A possible explanation for this puzzling result comes from the previous identification of complex Man 4 -and Man 5 -containing oligosaccharides from PRB3 (24) . Such structures may bind GNA but not be substrates of EndoD, which has a strict specificity for the oligomannosyl cores of glycoproteins (32) . The removal of these highmannose-type glycans from PRG during the growth of S. gordonii DL1 can be explained by the actions of BgaA and StrH on adjacent branches of the same oligosaccharide to expose ␣1-3-linked terminal Man, which is essential for the glycan recognition and subsequent cleavage by EndoD of S. pneumoniae (33) . A previously described mannosidase activity of S. gordonii and other viridans group streptococci (34) that acts on Man 5 glycoforms may also contribute to the removal of high-mannose-type glycans from PRG.
The sequential actions of BgaA, StrH, and EndoD on N-linked glycans of PRG are predicted to yield free Gal and GlcNAc, both of which support the growth of S. gordonii DL1 (3). As discussed above, the products of BgaA and EndoD are also likely to include fucosylated oligosaccharides. It is noteworthy that S. gordonii DL1, which does not grow on L-fucose, has genes for two putative ␣-L-fucosidases (i.e., SGO_0150 and SGO_1771) that are predicted to be cytoplasmic proteins. Recombinant proteins encoded by these genes were recently identified, respectively, as ␣1-2-and ␣1-3-and -4-specific ␣-L-fucosidases, based on their abilities to cleave fucosylated oligosaccharides (E. Guthrie, unpublished data). Thus, SGO_0150, which occurs as an isolated gene in S. gordonii DL1, may act on Fuc␣1-2Gal that is cleaved from PRG by the action of BgaA. Moreover, SGO_1771, which occurs in the previously described gom regulon (35) along with genes for a structurally characterized N-acetylglucosaminidase (36) and three putative mannosidases, may function in the metabolism of larger, Man-containing branched oligosaccharides that result from the action of EndoD. Indeed, inactivation of certain genes in the gom locus was found to reduce the growth of S. gordonii on both ␣1-6-D-mannobiose and GlcNAc␤1-2Man (35) . Further studies are needed to determine whether oligosaccharides released from basic PRG by cell surface GHs during the growth of S. gordonii DL1 in saliva are natural substrates of the intracellular glycoside hydrolases encoded by genes in the gom locus and at other loci.
